Prevalence of Selected Chronic Non-Communicable Diseases in Nepal.


Journal

Journal of Nepal Health Research Council
ISSN: 1999-6217
Titre abrégé: J Nepal Health Res Counc
Pays: Nepal
ID NLM: 101292936

Informations de publication

Date de publication:
14 Nov 2019
Historique:
received: 20 10 2019
accepted: 14 11 2019
entrez: 19 11 2019
pubmed: 19 11 2019
medline: 21 4 2020
Statut: epublish

Résumé

The burden of non-communicable diseases has increased in the last few decades in low-and middle-income countries including in Nepal. There is limited data on population based prevalence of non-communicable diseases. Hence, this study aims to determine the nationwide prevalence of selected chronic non-communicable diseases in Nepal. A nationwide cross-sectional population-based study was conducted from 2016 to 2018. Data was collected electronically on android device inbuilt with research and monitoring software from 13200 eligible participants aged 20 years and above. Data was cleaned in SPSS version 20.0 and analyzed using Stata version 13.1. The overall prevalence of selected non-communicable diseases was found to be chronic obstructive pulmonary disease 11.7% (95% CI: 10.5-12.9), diabetes mellitus 8.5% (95% CI: 7.8-9.3), chronic kidney disease 6.0% (95% CI: 5.5-6.6) and coronary artery disease 2.9% (95% CI: 2.4-3.4) in Nepal. Prevalence of non-communicable diseases varied across provinces. Higher prevalence of chronic obstructive pulmonary disease (25.1%, 95% CI: 18.1-33.8) in Karnali Province, diabetes (11.5%, 95% CI: 9.8-13.4) in Province 3, chronic kidney disease (6.8%, 95% CI: 5.6-8.1) in Gandaki Province and coronary artery disease in Gandaki (3.6%, 95% CI: 2.2-5.7) and Sudurpaschim Province (3.6%, 95% CI: 2.1-6.1) was observed. The study reported substantial proportion of adult population was found to have chronic non-communicable diseases in Nepal. The findings of this study may be useful for revising/updating multi-sectoral action plans on prevention and control of non-communicable diseases in Nepal.

Sections du résumé

BACKGROUND BACKGROUND
The burden of non-communicable diseases has increased in the last few decades in low-and middle-income countries including in Nepal. There is limited data on population based prevalence of non-communicable diseases. Hence, this study aims to determine the nationwide prevalence of selected chronic non-communicable diseases in Nepal.
METHODS METHODS
A nationwide cross-sectional population-based study was conducted from 2016 to 2018. Data was collected electronically on android device inbuilt with research and monitoring software from 13200 eligible participants aged 20 years and above. Data was cleaned in SPSS version 20.0 and analyzed using Stata version 13.1.
RESULTS RESULTS
The overall prevalence of selected non-communicable diseases was found to be chronic obstructive pulmonary disease 11.7% (95% CI: 10.5-12.9), diabetes mellitus 8.5% (95% CI: 7.8-9.3), chronic kidney disease 6.0% (95% CI: 5.5-6.6) and coronary artery disease 2.9% (95% CI: 2.4-3.4) in Nepal. Prevalence of non-communicable diseases varied across provinces. Higher prevalence of chronic obstructive pulmonary disease (25.1%, 95% CI: 18.1-33.8) in Karnali Province, diabetes (11.5%, 95% CI: 9.8-13.4) in Province 3, chronic kidney disease (6.8%, 95% CI: 5.6-8.1) in Gandaki Province and coronary artery disease in Gandaki (3.6%, 95% CI: 2.2-5.7) and Sudurpaschim Province (3.6%, 95% CI: 2.1-6.1) was observed.
CONCLUSIONS CONCLUSIONS
The study reported substantial proportion of adult population was found to have chronic non-communicable diseases in Nepal. The findings of this study may be useful for revising/updating multi-sectoral action plans on prevention and control of non-communicable diseases in Nepal.

Identifiants

pubmed: 31735938
doi: 10.33314/jnhrc.v17i3.2327
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

394-401

Auteurs

Meghnath Dhimal (M)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Khem Bahadur Karki (KB)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Sanjib Kumar Sharma (SK)

BP Koirala Institute of Health Sciences, Ghopa, Dharan, Nepal.

Krishna Kumar Aryal (KK)

Monitoring Evaluation and Operational Research (MEOR) Project, Abt Associates, Kathmandu, Nepal.

Namuna Shrestha (N)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Anil Poudyal (A)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Namra Kumar Mahato (NK)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Ashwin Karakheti (A)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Milesh Jung Sijapati (MJ)

KIST Medical College, Imadol, Lalitpur, Nepal.

Puspa Raj Khanal (PR)

Manmohan Memorial Institute of Health Sciences, Soltimode, Kathmandu, Nepal.

Suresh Mehata (S)

Ministry of Health and Population, Ramshah Path, Kathmandu, Nepal.

Abhinav Vaidya (A)

Kathmandu Medical College, Sinamangal, Kathmandu, Nepal.

Binod Kumar Yadav (BK)

Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal.

Krishna Prasad Adhikary (KP)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Anjani Kumar Jha (AK)

Nepal Health Research Council (NHRC), Ramshah Path, Kathmandu, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH